-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $58

Benzinga·08/17/2026 10:36:28
Listen to the news
Needham analyst Mike Matson initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $58.